Am J Physiol Lung Cell Mol Physiol


. 2021 Sep 15.
doi: 10.1152/ajplung.00619.2020. Online ahead of print.
ADAM10 Partially Protects Mice against Influenza Pneumonia by Suppressing Specific Myeloid Cell Population


Satoshi Okamori 1 2 , Makoto Ishii 1 , Takanori Asakura 1 , Shoji Suzuki 1 , Ho Namkoong 1 , Shizuko Kagawa 1 , Ahmed E Hegab 1 , Kazuma Yagi 1 , Hirofumi Kamata 1 , Tatsuya Kusumoto 1 , Takunori Ogawa 1 , Hayato Takahashi 3 , Masaki Yoda 4 , Keisuke Horiuchi 4 5 , Naoki Hasegawa 6 , Koichi Fukunaga 1



Affiliations

Abstract

The influenza virus infection poses a serious health threat worldwide. Myeloid cells play pivotal roles in regulating innate and adaptive immune defense. A disintegrin and metalloproteinase (ADAM) family of proteins contribute to various immune responses; however, the role of ADAM10 in influenza virus infection remains largely unknown. Herein, we investigated its role, focusing on myeloid cells, during influenza virus infection in mice. Adam10flox/flox/Lyz2-Cre (Adam10ΔLyz2) and control Adam10flox/flox mice were intranasally infected with 200 plaque-forming units of influenza virus A/H1N1/PR8/34. Adam10ΔLyz2 mice exhibited a significantly higher mortality rate, stronger lung inflammation, and a higher virus titer in the lungs than control mice. Macrophages and inflammatory cytokines such as TNF-α, IL-1b, and CCL2 were increased in bronchoalveolar lavage fluid from Adam10ΔLyz2 mice following infection. CD11b+Ly6G-F4/80+ myeloid cells, which had an inflammatory monocytes/macrophages-like phenotype, were significantly increased in the lungs of Adam10ΔLyz2 mice. Adoptive transfer experiments suggested that these cells likely contributed to the poorer prognosis in Adam10ΔLyz2 mice. Seven days after infection, CD11b+Ly6G-F4/80+ lung cells exhibited significantly higher arginase-1 expression levels in Adam10ΔLyz2 mice than in control mice, while an arginase-1 inhibitor improved the prognosis of Adam10ΔLyz2 mice. Enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF)/GM-CSF receptor signaling likely contributed to this process. Collectively, these results indicate that myeloid ADAM10 protects against influenza virus pneumonia and may be a promising therapeutic target.

Keywords: ADAM10; GM-CSF; inflammatory monocytes; influenza.